// App-Quantinova.ai

554 : Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

Researchers

Presenter

  • William A. Wood

Principal Investigators

  • Stephanie J. Lee

  • Ruta Brazauskas

  • Paulette Mehta

  • David Szwajcer

  • Steven Joffe

  • Navneet S. Majhail

  • Zhiwei Wang

  • Mahmoud D. Aljurf

  • Karen K. Ballen

  • David K. Buchbinder

  • Jason Dehn

  • Cesar O Freytes

  • Hillard M. Lazarus

  • Charles F. LeMaistre

Medical Centers

  • Hematology and Bone Marrow Transplant, Sarah Cannon, Nashville, TN

  • Children's Hospital of Orange County, Orange, CA

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • National Marrow Donor Program, Minneapolis, MN

  • CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis,

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR

  • Division of Hematology/Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC

  • Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

  • South Texas Veterans Health Care System, University of Texas Health Science Center at San Antonio, San Antonio, TX

  • Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI

  • Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA

  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH

Locations

  • United States

  • Canada

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved